Entia Biosciences, Inc. (ERGO)
OTCMKTS · Delayed Price · Currency is USD
0.0403
0.00 (0.00%)
At close: Mar 2, 2026
Entia Biosciences Market Cap
Entia Biosciences has a market cap or net worth of $1.37 million as of March 5, 2026. Its market cap has increased by 510.61% in one year.
Market Cap
1.37M
Enterprise Value
n/a
Revenue
265.47K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since January 18, 2008, Entia Biosciences's market cap has decreased from 3.26M to 1.37M, a decrease of -57.92%. That is a compound annual growth rate of -4.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 1.37M | 13,333.69% |
| Dec 31, 2025 | 10.22K | 50.00% |
| Dec 13, 2024 | 6.81K | - |
| Dec 27, 2022 | 6.81K | -86.67% |
| Dec 31, 2021 | 51.09K | -88.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neon Bloom | 1.85M |
| Carisma Therapeutics | 1.75M |
| Exousia Pro | 1.63M |
| inTerra Resources | 1.30M |
| Halberd | 1.20M |
| CERo Therapeutics Holdings | 1.15M |
| Sorrento Therapeutics | 1.14M |
| Evofem Biosciences | 1.14M |